Séverine Charles

1.3k total citations
20 papers, 814 citations indexed

About

Séverine Charles is a scholar working on Genetics, Molecular Biology and Genetics. According to data from OpenAlex, Séverine Charles has authored 20 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Séverine Charles's work include Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Séverine Charles is often cited by papers focused on Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Séverine Charles collaborates with scholars based in France, United States and Italy. Séverine Charles's co-authors include Federico Mingozzi, Fanny Collaud, Marcelo Simon Sola, Laetitia van Wittenberghe, Christian Leborgne, Giuseppe Ronzitti, Alban Vignaud, Solenne Marmier, Olivier Boyer and F. Jouen and has published in prestigious journals such as Nature Communications, Science Advances and Annals of the Rheumatic Diseases.

In The Last Decade

Séverine Charles

20 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Séverine Charles France 13 468 458 142 113 107 20 814
Fanny Collaud France 18 705 1.5× 700 1.5× 239 1.7× 154 1.4× 60 0.6× 32 1.1k
S. Hardy United States 3 287 0.6× 473 1.0× 137 1.0× 60 0.5× 100 0.9× 6 729
Gabriella Cotugno Italy 17 316 0.7× 383 0.8× 184 1.3× 135 1.2× 161 1.5× 37 792
Marcelo Simon Sola France 8 428 0.9× 406 0.9× 134 0.9× 97 0.9× 38 0.4× 11 621
Janik Adriaansen Netherlands 13 248 0.5× 205 0.4× 101 0.7× 27 0.2× 90 0.8× 19 456
Stefan Michelfelder Germany 14 444 0.9× 562 1.2× 87 0.6× 38 0.3× 128 1.2× 21 828
Lindsey A. George United States 15 754 1.6× 769 1.7× 403 2.8× 63 0.6× 49 0.5× 36 1.4k
Nina Mitchell United States 9 324 0.7× 276 0.6× 225 1.6× 21 0.2× 77 0.7× 14 765
Ariel Madrigal United States 9 161 0.3× 430 0.9× 211 1.5× 74 0.7× 626 5.9× 17 1.1k
Ekaterina Klimatcheva United States 11 167 0.4× 260 0.6× 95 0.7× 41 0.4× 153 1.4× 13 569

Countries citing papers authored by Séverine Charles

Since Specialization
Citations

This map shows the geographic impact of Séverine Charles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Charles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Charles more than expected).

Fields of papers citing papers by Séverine Charles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Charles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Charles. The network helps show where Séverine Charles may publish in the future.

Co-authorship network of co-authors of Séverine Charles

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Charles. A scholar is included among the top collaborators of Séverine Charles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Charles. Séverine Charles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhukouskaya, Volha V., Séverine Charles, Christian Leborgne, et al.. (2022). A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia. Yearbook of pediatric endocrinology. 1 indexed citations
2.
Barbon, Elena, Charlotte Kawecki, Solenne Marmier, et al.. (2021). Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. Gene Therapy. 30(3-4). 245–254. 25 indexed citations
3.
Zhukouskaya, Volha V., Séverine Charles, Christian Leborgne, et al.. (2021). A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia. Science Advances. 7(44). eabj5018–eabj5018. 5 indexed citations
4.
Parrini, Martina, Shovan Naskar, Ilaria Colombi, et al.. (2021). Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome. Molecular Therapy. 29(10). 3072–3092. 20 indexed citations
5.
Barbon, Elena, Jean‐François Ottavi, Charlotte Kawecki, et al.. (2020). Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors. EMBO Molecular Medicine. 12(4). e11298–e11298. 19 indexed citations
6.
Colella, Pasqualina, Manuel J. Gómez, Maria Grazia Biferi, et al.. (2020). Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects. EBioMedicine. 61. 103052–103052. 18 indexed citations
7.
Boisgérault, Florence, Corrado Guarnaccia, Alessandra Iaconcig, et al.. (2020). Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector. Molecular Therapy — Methods & Clinical Development. 20. 169–180. 14 indexed citations
8.
Cagin, Umut, Francesco Puzzo, Manuel J. Gómez, et al.. (2020). Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase. Molecular Therapy. 28(9). 2056–2072. 20 indexed citations
9.
Leborgne, Christian, Sylvie Boutin, Fanny Collaud, et al.. (2018). Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients. Cellular Immunology. 342. 103780–103780. 41 indexed citations
10.
Boisgérault, Florence, Romain Hardet, Solenne Marmier, et al.. (2018). Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications. 9(1). 4098–4098. 203 indexed citations
11.
Fitzpatrick, Zachary, Christian Leborgne, Elena Barbon, et al.. (2018). Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction. Molecular Therapy — Methods & Clinical Development. 9. 119–129. 136 indexed citations
12.
Colella, Pasqualina, Helena Costa Verdera, Francesco Puzzo, et al.. (2018). AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice. Molecular Therapy — Methods & Clinical Development. 12. 85–101. 54 indexed citations
13.
Colella, Pasqualina, Francesco Puzzo, Maria Grazia Biferi, et al.. (2017). Whole-body rescue of Pompe disease with AAV liver delivery of engineered secretable GAA transgenes. Neuromuscular Disorders. 27. S246–S246. 1 indexed citations
14.
Meliani, Amine, Florence Boisgérault, Zachary Fitzpatrick, et al.. (2017). Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors. Blood Advances. 1(23). 2019–2031. 102 indexed citations
15.
Vidal, Pierre, Giuseppe Ronzitti, Fanny Collaud, et al.. (2017). Adeno associated vector-based gene therapy strategy for type 3 glycogen storage disease. Neuromuscular Disorders. 27. S246–S246. 1 indexed citations
16.
Ronzitti, Giuseppe, Giulia Bortolussi, Remco van Dijk, et al.. (2016). A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome. Molecular Therapy — Methods & Clinical Development. 3. 16049–16049. 48 indexed citations
17.
Ronzitti, Giuseppe, Fanny Collaud, Giulia Bortolussi, et al.. (2016). 158. Cryptic ATG Removal from Synthetic Introns Increase the Therapeutic Efficacy of AAV Vector Mediated Gene Transfer. Molecular Therapy. 24. S62–S62. 1 indexed citations
18.
Ganapathy, Mathangi, et al.. (2015). Immunodiagnostic Properties of Wucheraria bancrofti SXP-1, a Potential Filarial Diagnostic Candidate Expressed in Tobacco Plant, Nicotiana tabacum. Applied Biochemistry and Biotechnology. 176(7). 1889–1903. 4 indexed citations
19.
Gérard, Xavier, Séverine Charles, Christian Pinset, et al.. (2009). Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene. Gene Therapy. 16(6). 815–819. 7 indexed citations
20.
Isenberg, David, C Dudeney, Ian E. Addison, et al.. (1987). Measurement of anti-DNA antibodies: a reappraisal using five different methods.. Annals of the Rheumatic Diseases. 46(6). 448–456. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fanny Collaud Breakdown of academic impact, for papers by S. Hardy Breakdown of academic impact, for papers by Gabriella Cotugno Breakdown of academic impact, for papers by Marcelo Simon Sola Breakdown of academic impact, for papers by Janik Adriaansen Breakdown of academic impact, for papers by Stefan Michelfelder Breakdown of academic impact, for papers by Lindsey A. George Breakdown of academic impact, for papers by Nina Mitchell Breakdown of academic impact, for papers by Ariel Madrigal Breakdown of academic impact, for papers by Ekaterina Klimatcheva
Rankless by CCL
2026